In a recent report, iron‐deficient mice with CKD receiving acute high dose EPO had no changes in iFGF23 after 6 and 24 hr, whereas iFGF23 was increased in normal, iron replete mice during the same timeframe (Hanudel, Eisenga, et al., 2018). The gene discussed is EPO; the disease is chronic kidney disease.